novo nordisk oral semaglutide brand name RYBELSUS® (semaglutide) tablets 7 mg or 14 mg List Price & Insurance Coverage Explained Novo Nordisk's oral GLP-1 drug

People who approach it as a sustained protocol rather than a quick intervention consistently report better outcomes and better experiences

Prefer a lighter texture on the face Some people do not like heavy or greasy creams, especially on the face

However, alcohol complicates GLP-1 therapy in other ways

Track and adjust Objective measurement beats subjective feeling every time

Track trends , not daily noise: use time-stamped logs for symptom type, meal timing, and hydration, allowing you to assess whether an intervention was effective over a two-week window

State Medicaid programs can still opt out of covering the obesity indications, and only 13 states covered GLP-1s for obesity under fee-for-service as of January 2026 ( [3] )